This opportunity is with a small (200+ employees) and growing novel oncology/hematology company. With their first product nearing launch, they are building up their commercial team. This company's CEO has a commercial background and is looking to put together a team of top tier Strategic Account Managers. The company also has multiple, late-phase, novel oncology/hematology molecules as well as an early phase I/O pipeline.

This opportunity comes with an excellent all-encompassing compensation package including a base in the 165k - 175k range, 40k uncapped incentive bonus, stock, a long-term incentive bonus with additional cash and stock, $1150 monthly auto allowance, and strong benefits. If interested in learning more, please apply today!